Delivery Order SPE2DB20D2104-SPE2DB22FT01S
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,388.08 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL insulin medication. The award is not designated with a set-aside requirement, indicating open competition. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,360.17, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a delivery order for Lantus Solostar 100 Unit/mL 3mL, a prescription insulin product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,729.38 firm fixed price delivery order is for the supply of 4,565,752,686 units of Lantus Solostar, a brand-name insulin product. The contract has a completion date of September 11, 2024 and was awarded on September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,005.70 firm fixed price delivery order is for the supply of Lantus Solostar 100 unit/ml 3ml, a brand name insulin product. The award is part of a single-award indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract has an ultimate completion date of March 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,068.84 firm-fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a prescription insulin medication. The contract has an ultimate completion date of September 30, 2024 and was awarded on September 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,562.80 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, which is a prescription insulin product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 4,565,520,096 units of the Lantus Solostar 100 unit/mL 3mL insulin medication. The $3,580.62 firm fixed-price delivery order has an ultimate completion date of August 21, 2024. This contract is not set aside for any specific business type. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,992.84 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Lantus Solostar 100 unit/ml 3ml, a prescription insulin medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,477.28 firm-fixed-price delivery order is for the supply of Lantus Solostar insulin delivery devices, which are a critical medical product used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT01SDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.20 firm fixed-price delivery order covers the supply of Lantus Solostar 100 unit/mL 3mL insulin medication. This award is associated with a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order did not have a set-aside designation, indicating open competition. The contract supports the medical needs of military personnel, veterans, and other federal beneficiaries through the provision of essential pharmaceutical and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/14/22 |